StockTipsArenaBeta

BUY Laurus Labs Ltd — Deven Mehata, IDBI Capital Markets and Securities

BUYLaurus Labs Ltd
Laurus Labs share price target & all analyst calls

byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: NA (inferred 1–3 months)29 Jun 2026via CNBC Awaaz.

Entry₹1,480Stated
Target₹1,625
Total upside +9.80% (call closed)
Stop loss₹1,430-3.38% risk
Exit₹1,62527 Jul 2026, 12:07 pm
Target hit+9.80%0.00%upside left
Follow Deven Mehata for new callsGet alertsWatch LAURUSLABS for new buy/sell callsGet alertsSee 3 active Short-term calls on LAURUSLABSSee 39 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 27 Jul 2026
5 supporting8 neutral2 opposing
Supports the BUY call (5)

Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth

NewsEt-Markets·27 Jul · today

(opens in new tab)

2 advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·26 Jul · yesterday

Laurus Labs Q1 Results: Stock jumps after margins cross 30%, other parameters beat

NewsCnbc-Tv18·24 Jul · 2d ago

(opens in new tab)

Laurus Labs announced its Q1 FY27 financial results, reporting a revenue of ₹2,026 Cr, a 29% increase year-on-year. EBITDA stood at ₹644 Cr, up 66% with margins at 31.8%. The company highlighted stron

NSE · Press Release·24 Jul · 2d ago

(opens in new tab)

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·30 Jun · 4w ago

Neutral / worth noting (8)

Nifty in oversold territory; pullback to 24,000 possible: Analysts

NewsEt-Markets·27 Jul · today

(opens in new tab)

Laurus Labs Limited has disclosed information regarding a composite scheme of arrangement involving its subsidiaries, Laurus Synthesis Private Limited and Sriam Labs Private Limited. The National Comp

BSE · Company Update·25 Jul · yesterday

(opens in new tab)

Laurus Labs Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The press release is enclosed for information.

BSE · Company Update·24 Jul · 2d ago

(opens in new tab)

Laurus Labs Ltd announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved at a Board Meeting held on July 24,

BSE · Board Meeting·24 Jul · 2d ago

(opens in new tab)

Laurus Labs Limited announced its unaudited financial results for the quarter ended June 30, 2026. The results were approved by the Board of Directors.

NSE · Outcome of Board Meeting·24 Jul · 2d ago

(opens in new tab)
Weighs against the BUY call (2)

1 other SEBI-registered advisor has an active short-term SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·27 Jul · today

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·28 Oct · 9mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Laurus Labs

All analyst calls on Laurus Labs

More from Deven Mehata, IDBI Capital Markets and Securities

Every call and its outcome